Effect of Advancing Age on Outcomes of Therapy for Clostridium difficile Infection.

Effect of Advancing Age on Outcomes of Therapy for Clostridium difficile Infection.

Detalhes bibliográficos
Principais autores:	Louie, T, Miller, M, Crook, D, Lentnek, A, Bernard, L, High, K, Shue, Y, Gorbach, S
Formato:	Conference item
Publicado em:	2011

Registros relacionados

Effect of age on treatment outcomes in Clostridium difficile infection.
por: Louie, T, et al.
Publicado em: (2013)

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
por: Cornely, O, et al.
Publicado em: (2012)

Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
por: Mullane, K, et al.
Publicado em: (2013)

Factors Influencing Time to Resolution of Diarrhea in Patients with Clostridium difficile Infection Treated with Fidaxomicin or Vancomycin.
por: Gerding, D, et al.
Publicado em: (2012)

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
por: Christine Lee, et al.
Publicado em: (2016-01-01)

Effect of Proton Pump Inhibitors (PPI) and H2 Receptor Antagonists (H2RA) on Response to Therapy with Fidaxomicin or Vancomycin in Hospitalized Patients with Clostridium difficile Infection
por: Weiss, K, et al.
Publicado em: (2011)

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
por: Crook, D, et al.
Publicado em: (2012)

Nature’s Therapy for Recurrent Clostridium Difficile Diarrhea
por: Thomas Louie, et al.
Publicado em: (2008-01-01)

Clostridium difficile mixed infection and reinfection.
por: Eyre, D, et al.
Publicado em: (2012)

Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection.
por: Sears, P, et al.
Publicado em: (2012)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Thomas Louie, et al.
Publicado em: (2015-12-01)

Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection.
por: Stoesser, N, et al.
Publicado em: (2011)

Regarding "Clostridium difficile ribotype does not predict severe infection".
por: Walker, A, et al.
Publicado em: (2013)

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile
por: Eyre, D, et al.
Publicado em: (2013)

Effects of control interventions on Clostridium difficile infection in England: an observational study
por: Dingle, K, et al.
Publicado em: (2017)

Immunization strategies for Clostridium difficile infections.
por: Rebeaud, F, et al.
Publicado em: (2012)

Yersinia Infection with Clostridium Difficile Colitis
por: M.J. Fishman, et al.
Publicado em: (1989-01-01)

Assessment of Severity of Clostridium difficile Infection
por: Subrata Ghosh
Publicado em: (2011-01-01)

Guidelines for Clostridium difficile infection in adults
por: Michał Kukla, et al.
Publicado em: (2020-03-01)

Tea and Recurrent Clostridium difficile Infection
por: Martin Oman Evans II, et al.
Publicado em: (2016-01-01)

Differences in outcome according to Clostridium difficile testing method: A prospective multicentre diagnostic validation study of C difficile infection
por: Planche, T, et al.
Publicado em: (2013)

Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
por: Planche, T, et al.
Publicado em: (2013)

Clostridium difficile in Clinical Practice: Increasing Rates, More Virulent Organisms and New Therapies on the Horizon
por: Thomas J Louie
Publicado em: (2006-01-01)

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
por: Cornely, O, et al.
Publicado em: (2012)

Patient and strain characteristics associated with Clostridium difficile transmission and adverse outcomes
por: Martin, J, et al.
Publicado em: (2018)

Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains
por: Stoesser, N, et al.
Publicado em: (2017)

Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
por: Eyre, D, et al.
Publicado em: (2012)

Multilocus sequence typing of Clostridium difficile.
por: Griffiths, D, et al.
Publicado em: (2010)

Clostridium difficile infection: clinico-epidemiological perspective.
por: SYUHADA N,, et al.
Publicado em: (2013)

Infections caused by Clostridium difficile in cancer patients
por: I. A. Klyuchnikova, et al.
Publicado em: (2019-01-01)

Clostridium difficile Infection: A Worldwide Disease
Publicado em: (2014-01-01)

Clostridium difficile Outbreaks
por: Paul Bayardelle
Publicado em: (2007-01-01)

Asymptomatic Clostridium difficile colonisation and onward transmission
por: Eyre, D, et al.
Publicado em: (2013)

The Complexity and Diversity of the Pathogenicity Locus in Clostridium difficile Clade 5.
por: Elliott, B, et al.
Publicado em: (2014)

Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
por: Schlackow, I, et al.
Publicado em: (2012)

Fairness of financial penalties to improve control of Clostridium difficile.
por: Walker, A, et al.
Publicado em: (2008)

Fairness of financial penalties to improve control of Clostridium difficile.
por: Walker, A, et al.
Publicado em: (2008)

Clostridium difficile in 7 European countries and North America: Fidaxomicin vs vancomycin therapy
por: Crook, D, et al.
Publicado em: (2012)

Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication
Publicado em: (2016-03-01)

Evolutionary history of the Clostridium difficile pathogenicity locus.
por: Dingle, K, et al.
Publicado em: (2014)